Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 浙江仙琚制药股份有限公司是一家医药制造企业,公司主要从事于甾(zāi)体原料药和制剂的研制、生产与销售,主要产品分为皮质激素类药物、性激素类药物(妇科及计生用药)和麻醉与肌松类药物三大类,是国内规模最大、品种最为齐全的甾体药物生产厂家.公司是国家火炬计划重点高新技术企业、浙江省高新技术企业、浙江省重点化学制药骨干企业、2005年和2007年浙江省医药十强企业.公司取得了30余项省级以上科研公司已拥有6项发明专利,另有9项专利申请已获受理.公司已在6个国家和地区总计23种产品取得了国际认证,其中,有4种产品取得了美国FDA认证,2种产品获得了欧洲COS认证.公司的维库溴铵及其注射剂项目、匹多莫德原药及颗粒剂项目和糠酸莫米松及乳膏项目被列入国家级火炬计划项目;醋酸烯诺酮及其一根型皮下埋植剂被列入"十五"国家科技攻关项目;抗早孕一类新药赛米司酮ZXH951被列入国家"863"项目;地塞米松系列产品的"绿色生产技术与示范"列入国家科技支撑计划(获得的国家资助与"863"项目相当);甲基泼尼松龙为浙江省重大科技攻关项目。
Main Business 甾体原料药和制剂的研制、生产与销售。
Legal Representative 张宇松
Top Executives
董事长：张宇松
董事：张国钧,陈卫武,张王伟,金炜华,曹保湖
独立董事：刘斌,郝云宏,张红英
Top 5 Shareholder
Shareholder name Nature Holding Date
仙居县产业投资发展集团有限公司流通A股21.55%30/09/2024
中国人寿保险股份有限公司－传统－普通保险产品－005L－CT001沪流通A股1.82%30/09/2024
招商银行股份有限公司－兴业兴睿两年持有期混合型证券投资基金流通A股1.54%30/09/2024
国泰佳泰股票专项型养老金产品－招商银行股份有限公司流通A股1.46%30/09/2024
李勤俭流通A股1.38%30/09/2024
Company Secretary 张王伟
Solicitors 上海市锦天城律师事务所
Auditors 天健会计师事务所（特殊普通合伙）
Tel No 0576-87730127;0576-87731138
Fax No 0576-87774487
Website www.xjpharma.com
Email xy@xjpharma.com;dmb@xjpharma.com
Company Address
Register: 浙江省台州市仙居县仙药路1号
Office: 浙江省仙居县福应街道现代工业集聚区丰溪西路15号
Listing Date 12/01/2010
Shares Capital
Shares Capital: 989,204,866
Total A Share: 989,204,866
Listed A Share: 984,193,551
Non-tradable A Share: 5,011,315
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.570
DPS(RMB)* ¥ 0.300
NBV Per Share(RMB)* ¥ 5.849
Market Capitalization(RMB) 9.360B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.